Invivo Therapeutics HoldingsNVIVQ
13F holders, Q4 2025 (December 31)1holders −3
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Invivo Therapeutics Holdings (NVIVQ) in their 13F filings, down 3 from Q1 2024. 1 opened new positions and 0 sold out. The largest holder was Motiv8 Investments LLC ($0).
- Company
- Invivo Therapeutics Holdings
- CUSIP
- 46186M605
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q4 2025: 1 shares bought, net +1 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Motiv8 Investments LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is NVIVQ's weight in each manager's 13F, not the share of Invivo Therapeutics Holdings the manager owns.